$CCRN

Ball Susan E sold (to issuer) $4.2M of CCRN

Ball Susan E (General Counsel and Secretary) sold (to issuer) 314,649 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($4.17M total) across 2 trades on 2026-07-21.

Original reporting
SEC EDGAR · Ball Susan E
Published Jul 21, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
medium confidence
Mentioned
$CCRN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity (314,649 shares at $13.25) but does not introduce new company fundamentals, guidance, or legal/regulatory developments.

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone is unlikely to drive a durable repricing without additional fundamental catalysts.

03

What to watch

No 10b5-1 plan is stated, but the filing does not provide intent or context for the sale; without accompanying company news, trading impact should be limited.

Relevance 6/10Novelty 3/10Timing: Filed 2026-07-21 after-hours on SEC EDGAR.

Background

The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare, Inc. (CCRN).

Company-level read

Ticker impact

$CCRNNeutralMedium confidence
Context

Cross Country Healthcare insider Ball Susan E sold 314,649 shares to the issuer on 2026-07-21 at $13.25, leaving 0 shares.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived and sentiment-driven.

Evidence & confidence

Form 4 shows a sale to the issuer (code D) and the filing does not indicate new operating information, guidance, or regulatory action. The insider ends with 0 shares, but the transaction type suggests a planned/administrative mechanism rather than a fundamental signal.

Market effects

Minimal; this is company-specific insider transaction data with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the transaction is coded as a sale to the issuer and the insider has 0 shares afterward, it may reflect administrative liquidity or plan mechanics rather than bearish expectations.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction disclosure.

  • Ball Susan E

    General Counsel and Secretary who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).